201 related articles for article (PubMed ID: 16511411)
1. Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females.
Wichukchinda N; Nakayama EE; Rojanawiwat A; Pathipvanich P; Auwanit W; Vongsheree S; Ariyoshi K; Sawanpanyalert P; Shioda T
AIDS; 2006 Jan; 20(2):189-96. PubMed ID: 16511411
[TBL] [Abstract][Full Text] [Related]
2. Association of RANTES -403 G/A, -28 C/G and In1.1 T/C polymorphism with HIV-1 transmission and progression among North Indians.
Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
J Med Virol; 2008 Jul; 80(7):1133-41. PubMed ID: 18461620
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary study on the association of chemokine RANTES gene polymorphisms with HIV-1 infection in Chinese Han population].
Liu XL; Wang FS; Jin L; Liu MX; Xu DZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):971-5. PubMed ID: 14687494
[TBL] [Abstract][Full Text] [Related]
4. Effects of single nucleotide polymorphisms in the RANTES promoter region in healthy and HIV-infected indigenous Chinese.
Zhao XY; Lee SS; Wong KH; Chan KC; Ma S; Yam WC; Yuen KY; Ng MH; Zheng BJ
Eur J Immunogenet; 2004 Aug; 31(4):179-83. PubMed ID: 15265023
[TBL] [Abstract][Full Text] [Related]
5. RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs.
Koizumi Y; Kageyama S; Fujiyama Y; Miyashita M; Lwembe R; Ogino K; Shioda T; Ichimura H
AIDS Res Hum Retroviruses; 2007 May; 23(5):713-9. PubMed ID: 17530998
[TBL] [Abstract][Full Text] [Related]
6. Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.
Boulassel MR; Smith GH; Edwardes MD; Young M; Klein M; Gilmore N; Macleod J; Leblanc R; René P; Allan J; Lalonde RG; Routy JP
HIV Med; 2005 Jul; 6(4):268-77. PubMed ID: 16011532
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load.
Nakayama EE; Meyer L; Iwamoto A; Persoz A; Nagai Y; Rouzioux C; Delfraissy JF; Debre P; McIlroy D; Theodorou I; Shioda T;
J Infect Dis; 2002 Apr; 185(8):1183-6. PubMed ID: 11930331
[TBL] [Abstract][Full Text] [Related]
8. RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression.
Paxton WA; Neumann AU; Kang S; Deutch L; Brown RC; Koup RA; Wolinsky SM
J Infect Dis; 2001 Jun; 183(11):1678-81. PubMed ID: 11343219
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load.
Singh KK; Hughes MD; Chen J; Spector SA
J Infect Dis; 2005 Jun; 191(11):1971-80. PubMed ID: 15871132
[TBL] [Abstract][Full Text] [Related]
10. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
[TBL] [Abstract][Full Text] [Related]
11. The effect of stromal cell-derived factor 1 (SDF1/CXCL12) genetic polymorphism on HIV-1 disease progression.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Kaminami Morimoto H; Akira Morimoto A; Wiechmann SL; Breganó JW; Matsuo T; Vissoci Reiche F; Miranda HC; Brajão Oliveira K; Vogler IH; Siscar AR
Int J Mol Med; 2006 Oct; 18(4):785-93. PubMed ID: 16964435
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma.
Kleinrath T; Gassner C; Lackner P; Thurnher M; Ramoner R
J Clin Oncol; 2007 Mar; 25(7):845-51. PubMed ID: 17327605
[TBL] [Abstract][Full Text] [Related]
13. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
Erikstrup C; Kallestrup P; Zinyama-Gutsire RB; Gomo E; Butterworth AE; Pedersen BK; Ostrowski SR; Gerstoft J; Ullum H
AIDS; 2007 Nov; 21(17):2283-91. PubMed ID: 18090276
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression.
Chuenchitra T; Wasi C; de Souza M; Nitayaphan S; Louisirirotchanakul S; Sutthent R; Brown AE; Birx DL; Polonis VR
Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):856-62. PubMed ID: 19058580
[TBL] [Abstract][Full Text] [Related]
15. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
16. Modulating influence on HIV/AIDS by interacting RANTES gene variants.
An P; Nelson GW; Wang L; Donfield S; Goedert JJ; Phair J; Vlahov D; Buchbinder S; Farrar WL; Modi W; O'Brien SJ; Winkler CA
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10002-7. PubMed ID: 12114533
[TBL] [Abstract][Full Text] [Related]
17. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
[TBL] [Abstract][Full Text] [Related]
18. CCL5/RANTES chemokine gene promoter polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population.
Muro M; Marín L; Torio A; Pagan JA; Alvarez-López MR
Int J Immunogenet; 2008 Feb; 35(1):19-23. PubMed ID: 18186796
[TBL] [Abstract][Full Text] [Related]
19. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
[TBL] [Abstract][Full Text] [Related]
20. Virologic and host characteristics of human immunodeficiency virus type 1-infected pediatric long term survivors.
Alexander L; Cuchura L; Simpson BJ; Andiman WA
Pediatr Infect Dis J; 2006 Feb; 25(2):135-41. PubMed ID: 16462290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
